/
SIGA Technologies, Inc. is referred to throughout this report as SIGA, the Company, we or us. The Company sells its lead product, TPOXX ( oral TPOXX , also known as "tecovirimat," "Tecovirimat-SIGA," or "TEPOXX (tecovirimat)" in certain international markets), to the U.S.
$3.44
$0.12 (-3.37%)
EOD Jul 17, 2026
25.06% operating margin is above average. ROIC at 7.97%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 31.8% YoY. Margins deteriorated 25.4pp alongside, both lines moving the wrong way.
Free cash flow declined 12% versus the prior year, cash generation momentum has weakened. ROIC dropped from 25.63% to 7.97%, capital efficiency is deteriorating.
12.3x earnings, 9.0x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$94M
▼ -31.8% YoY
Net Income (TTM)
$20M
▼ -60.7% YoY
Op. Margin
22.01%
▼ -25.4pp YoY
ROIC
7.28%
▼ -17.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$27M
▼ -11.5% YoY
Op. Cash Flow (TTM)
$28M
▼ -10.8% YoY
Net Debt
-$145M
Net Cash Position
Cash & Equiv.
$146M
5Y CAGR: -5.4%
5Y CAGR: -9.6%
Continue Research
At a P/E of 12.3 and a price-to-free-cash-flow of 9.0, Siga Technologies (SIGA) trades below a two-stage DCF intrinsic value of about $20.36 per share, so at $3.44 the stock looks undervalued (491.9% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Siga Technologies scores 44/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 17.6%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $20.36 per share for SIGA, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $15.27. At today's $3.44, that puts the stock about 491.9% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Siga Technologies scores 44 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 22.0% operating margin and a 7.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Siga Technologies pays a regular dividend of about $0.60 per share per year (typically in quarterly installments), a yield of roughly 17.6% at the current price. That is a payout ratio of about 213.9% of earnings, so the dividend is stretched at this level. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For SIGA's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. SIGA currently trades below its estimated intrinsic value and scores 44/100 on quality (mixed). It also yields about 17.6%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.